会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • System And Method For Determining The Origin Of A Sensed Beat
    • 确定感觉节拍的起源的系统和方法
    • US20080281369A1
    • 2008-11-13
    • US11745667
    • 2007-05-08
    • Bruce KenKnightSteven D. Girouard
    • Bruce KenKnightSteven D. Girouard
    • A61N1/36
    • A61B5/04525A61B5/042A61B5/0456A61B5/7239A61N1/3702
    • A method for monitoring a biological cardiac pacemaker is provided. The method may include stimulating a heart at a region selected for implantation of a biological pacemaker and sensing at least one electrical signal indicative of a cardiac depolarization originating in the region selected for implantation of the biological pacemaker. The method may further include sensing at least one subsequent electrical signal produced by the heart and determining if the subsequent electrical signal originated in the region selected for the biological pacemaker or another region of the heart. In an alternative embodiment, the method may include determining a template time difference between two points on cardiac complexes sensed in two or more different cardiac locations during normal sinus rhythm. The method may further include determining a time difference between two points on a subsequent cardiac complex sensed in two or more different cardiac locations. The time differences may be compared to determine if the subsequently-sensed cardiac complex originates in a left ventricular biological pacemaker site or in another cardiac site.
    • 提供了一种用于监测生物心脏起搏器的方法。 该方法可以包括在选择用于植入生物起搏器的区域处刺激心脏,并感测至少一个电信号,其指示源于选择用于植入生物起搏器的区域的心脏去极化。 该方法还可以包括感测由心脏产生的至少一个随后的电信号,并确定后续的电信号是否起源于为生物起搏器或心脏另一区域选择的区域。 在替代实施例中,该方法可以包括确定在正常窦性心律期间在两个或更多个不同心脏位置中感测到的心脏复合体上的两个点之间的模板时间差。 该方法还可以包括确定在两个或更多个不同心脏位置中感测到的随后的心脏复合体上的两个点之间的时间差。 可以比较时间差以确定随后感测的心脏复合物是否起源于左心室生物起搏器位点或另一心脏位点。
    • 9. 发明申请
    • APPARATUS FOR PROVIDING ON-PATIENT COMMUNICATION
    • 用于提供患者通信的装置
    • US20090069867A1
    • 2009-03-12
    • US12240706
    • 2008-09-29
    • Bruce KenKnightGust H. Bardy
    • Bruce KenKnightGust H. Bardy
    • A61N1/08
    • G06Q50/24A61B5/0031G06F19/3418G16H10/60G16H40/63G16H50/30Y10S128/903Y10S128/904
    • An apparatus for providing on-patient communication is described. An implantable medical device including a sensor of physiometry is implanted in a patient. A communication module is remotely interconnected to an interrogation device external to the patient's body and the physiometry is exchanged with the interrogation device. Spoken communication from the patient is received by an implantable microphone including a communication module and is relayed to the interrogation device. voice prompts received from the interrogation device are played by An implantable speaker including a communication module. Pre-defined uniquely identifying patient characteristics are further included with at least one of the implantable medical device, implantable microphone, and implantable speaker and the characteristics are presented on demand by the communication module of the implantable medical device, implantable microphone, and implantable speaker.
    • 描述了一种用于提供门诊通信的装置。 将包括物理测量传感器的可植入医疗装置植入患者体内。 通信模块远程互连到病人身体外部的询问装置,并且与询问装置交换物理学。 来自患者的口语通信由包括通信模块的可植入麦克风接收并被中继到询问设备。 由询问装置接收到的语音提示由包括通信模块的可植入扬声器播放。 可植入医疗装置,可植入麦克风和可植入扬声器中的至少一个进一步包括预定义的唯一识别患者特征,并且根据需要由可植入医疗装置,可植入麦克风和可植入扬声器的通信模块呈现特征。
    • 10. 发明申请
    • Method For Controlling Pacemaker Therapy
    • 控制起搏器治疗的方法
    • US20080281371A1
    • 2008-11-13
    • US11745823
    • 2007-05-08
    • Bruce KenKnightSteven D. Girouard
    • Bruce KenKnightSteven D. Girouard
    • A61N1/365
    • A61N1/365A61B5/0468A61N1/36514A61N1/36592A61N1/3688A61N1/3702
    • The present invention includes a method for controlling pacemaker therapy in a patient with an implanted biological pacemaker. The method may include pacing a heart at a predetermined rate using an electronic pacemaker and configuring the pacemaker to periodically enter a biological pacemaker weaning mode. The weaning mode may include ceasing pacing for at least a predetermined length of time and monitoring the heart to detect electrical depolarizations of a ventricle of the heart during the predetermined length of time. The weaning mode may further include determining the length of time between the cessation of pacing and the detected electrical depolarization and determining if the length of time between the cessation of pacing and the detected electrical depolarization is less than a maximum predetermined interval. The pacemaker therapy may be withheld as long as the length of time is less than the maximum predetermined interval. Further, if the length of time exceeds a maximum interval, the pacemaker will exit the weaning mode.
    • 本发明包括一种用植入式生物起搏器控制患者起搏器治疗的方法。 该方法可以包括使用电子起搏器以预定速率起搏心脏并且配置起搏器周期性地进入生物起搏器断奶模式。 断奶模式可以包括停止至少预定时间长度的起搏并监测心脏以在预定时间长度内检测心脏心室的电去极化。 断奶模式还可以包括确定停止起搏和检测到的电去极化之间的时间长度,并确定停止起搏和检测到的电去极化之间的时间长度是否小于最大预定间隔。 只要时间长度小于最大预定间隔,就可以禁止起搏器治疗。 此外,如果时间长度超过最大间隔,则起搏器将退出断奶模式。